Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

112.41

+3.92 (3.61%)

At close: Aug 12, 2026, 4:00 PM EDT

112.41

0.00 (0.00%)

After-hours: Aug 12, 2026, 4:15 PM EDT

Dianthus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	110.55	51.09	22.79	132.33	15.37	131.65
Short-Term Investments	776.26	353.21	252.45	41.39	60.13	45.28
Cash & Short-Term Investments	886.81	404.3	275.24	173.72	75.49	176.93
Cash Growth	244.54%	46.89%	58.44%	130.12%	-57.33%	18.87%
Accounts Receivable	0.11	0.05	-	-	-	-
Other Receivables	-	-	0.81	0.48	5.64	-
Total Trade Receivables	0.11	0.05	0.81	0.48	5.64	-
Other Current Assets	10.62	5.09	4.86	3.26	0.91	3.77
Total Current Assets	897.54	409.44	280.9	177.45	82.03	180.69
Net Property, Plant & Equipment	1.64	1.63	1.75	0.8	0.96	7.46
Long-Term Investments	303.63	110.14	81.73	-	-	-
Other Long-Term Assets	10.46	9.72	9.63	1.15	0.12	1.78
Total Assets	1,213	530.92	374.01	179.41	83.11	189.93
Accounts Payable	6.39	9.73	4.58	2.61	1.17	3.04
Accrued Expenses	26.1	19.45	13.07	6.5	6.61	7.82
Current Portion of Leases	0.37	0.37	0.32	0.42	0.35	-
Unearned Revenue	1.52	1.19	0.48	0.1	0.1	-
Total Current Liabilities	34.39	30.73	18.45	9.63	8.23	10.86
Long-Term Leases	0.91	1.02	1.17	0.17	0.44	-
Other Long-Term Liabilities	5.94	5.77	1.91	0.74	0.79	6.4
Total Long-Term Liabilities	6.86	6.79	3.08	0.9	1.23	6.4
Total Liabilities	41.25	37.52	21.53	10.54	9.45	17.26
Common Stock	0.06	0.04	0.03	0.02	-	0.06
Additional Paid-in Capital	1,602	829.6	526.73	258.23	1.66	498.21
Accumulated Other Comprehensive Income	-2.13	0.49	0.11	0.05	-0.16	-0.03
Retained Earnings	-427.78	-336.73	-174.39	-89.42	-45.87	-325.57
Total Common Shareholders' Equity	1,172	493.4	352.48	168.87	-44.37	172.67
Minority Interest	-	-	-	-	118.02	-
Shareholders' Equity	1,172	493.4	352.48	168.87	73.66	172.67
Total Liabilities & Equity	1,213	530.92	374.01	179.41	83.11	189.93
Total Debt	1.29	1.39	1.49	0.59	0.79	0
Net Cash (Debt)	885.53	402.91	273.75	173.13	74.7	176.93
Net Cash Growth	245.83%	47.18%	58.12%	131.76%	-57.78%	18.87%
Net Cash Per Share	18.96	10.43	8.22	33.60	85.45	202.56
Book Value	1,172	493.4	352.48	168.87	-44.37	172.67
Book Value Per Share	25.09	12.78	10.58	32.77	-50.75	197.69
Tangible Book Value	1,172	493.4	352.48	168.87	-44.37	172.67
Tangible Book Value Per Share	25.09	12.78	10.58	32.77	-50.75	197.69

SEC Filings: 10-K · 10-Q